ArticleMolecular medicine reports2020

Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC.

Rong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.